Skip to main content
Log in

Pelvic inflammatory disease and contraceptive practice

  • Published:
Advances in Contraception

Abstract

Analyses of data from the Women's Health Study suggest that the relative risks of hospitalization for PID were lower for women with tubal sterilizations and women whose partners had been sterilized (p<0.05), compared to sexually active non-contraceptors or women using oral or barrier methods. Further studies should be conducted to evaluate this non-contraceptive benefit of sterilization.

Resumé

Des analyses de résultats du Women's Health Study indiquent que les risques relatifs d'hospitalisation pour inflammation pelvienne sont plus faibles chez des femmes ayant subi une stérilisation tubaire et des femmes dont le partenaire a été stérilisé (p<0.05), que pour des femmes sexuellement actives et n'utilisant aucune méthode contraceptive, ou utilisant des contraceptifs oraux ou des barrières. D'autres études devront être effectuées afin d'évaluer les avantages non contraceptifs de la stérilisation.

Sumario

Análisis de datos del Estudio Salud de la Mujer, sugiere que los riesgos relativos de hospitalización por inflamación pelviana (PID) fueron más bajos para mujeres con esterilización tubaria y mujeres cuyos compañeros han sido esterilizados (p<0.05) comparados con mujeres sexualmente activas que no usaban anticonceptivos o mujeres usando la píldora o métodos de barrera. Estudios adicionales deberán ser hechos a fin de evaluar este beneficio no anticonceptivo de la esterilización.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. BurkmanR. T. and The Women's Health Study. (1981). Association between intrauterine device and pelvic inflammatory disease.Obstet. Gynecol.,57, 269–276

    PubMed  Google Scholar 

  2. LeeN. C., RubinG. L., OryH. W. and BurkmanR. T. (1983). Type of intrauterine device and the risk of pelvic inflammatory disease.Obstet. Gynecol.,62, 1–6

    PubMed  Google Scholar 

  3. StadlB. V. and SchlesselmanS. (1984). Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use.Obstet. Gynecol.,63, 171–178

    PubMed  Google Scholar 

  4. KelaghanJ., RubinG. L., OryH. W. and LaydeP. M. (1982). Barrier method contraceptives and pelvic inflammatory disease.J. Am. Med. Assoc.,248, 184–187

    Google Scholar 

  5. RubinG. L., OryH. W. and LaydeP. M. (1982). Oral contraceptives and pelvic inflammatory disease.Am. J. Obstet. Gynecol.,144, 630–635

    PubMed  Google Scholar 

  6. SchlesselmanJ. J. (1982).Case-Control Studies. Design, Conduct, Analysis, Oxford University Press, New York

    Google Scholar 

  7. WashingtonA. E., GoveS., SchachterJ. and SweetR. L. (1985). Oral contraceptives.Chlamydia trachomatis infection, and pelvic inflammatory disease.J. Am. Med. Assoc.,253, 2246–2250

    Google Scholar 

  8. TothA., LesserM. L. and LabriolaD. (1984). The development of infections of the genitourinary tract in the wives of infertile males and the possible role of spermatozoa in the development of salpingitis.Surg. Gynecol. Obstet.,159, 565–569

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edelman, D.A. Pelvic inflammatory disease and contraceptive practice. Adv Contracept 2, 141–144 (1986). https://doi.org/10.1007/BF01849223

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849223

Keywords

Navigation